New Haven, Connecticut, United States
Contact Info
594 followers
500+ connections
New Haven, Connecticut, United States
Contact Info
594 followers
500+ connections
Activity
-
Very good article in the Financial Times with fantastic graphics about CAR T-cell therapy and the story of the world's 3rd patient with lupus who…
Very good article in the Financial Times with fantastic graphics about CAR T-cell therapy and the story of the world's 3rd patient with lupus who…
Liked by Mohosin Sarkar
-
Good to see our work captured in this good overview about publication trends on bispecific antibodies from 2000-2023 by Ming Liu and colleagues…
Good to see our work captured in this good overview about publication trends on bispecific antibodies from 2000-2023 by Ming Liu and colleagues…
Liked by Mohosin Sarkar
-
I'm looking forward to presenting on the mBio Early-Career Editorial Board at next week's ISMTE 2024 North American Conference! Check out this…
I'm looking forward to presenting on the mBio Early-Career Editorial Board at next week's ISMTE 2024 North American Conference! Check out this…
Liked by Mohosin Sarkar
Experience & Education
-
EvolveImmune Therapeutics
View Mohosin’s full experience
See their title, tenure and more.
or
More activity by Mohosin
-
TRIM21 is an intracellular Fc receptor. What's the purpose of an intracellular Fc receptor when antibodies don't enter the cell?! Well it turns out…
TRIM21 is an intracellular Fc receptor. What's the purpose of an intracellular Fc receptor when antibodies don't enter the cell?! Well it turns out…
Liked by Mohosin Sarkar
-
Our review article on reversing T cell exhaustion in cancer is now featured in the AACR Journals collection on immunotherapy. #CancerResearch…
Our review article on reversing T cell exhaustion in cancer is now featured in the AACR Journals collection on immunotherapy. #CancerResearch…
Liked by Mohosin Sarkar
-
Thanks Mike for your hospitality and great discussions! #CD2Costimulation #Collaboration #Oxford #EvolveImmune
Thanks Mike for your hospitality and great discussions! #CD2Costimulation #Collaboration #Oxford #EvolveImmune
Liked by Mohosin Sarkar
-
Many thanks to the organizers for the opportunity to present our recent progress. Great discussions with so many colleagues on emerging approaches to…
Many thanks to the organizers for the opportunity to present our recent progress. Great discussions with so many colleagues on emerging approaches to…
Liked by Mohosin Sarkar
-
Looking forward to attending Antibody Engineering & Therapeutics Europe with my colleague #JeremyMyers. We will be presenting on the latest progress…
Looking forward to attending Antibody Engineering & Therapeutics Europe with my colleague #JeremyMyers. We will be presenting on the latest progress…
Liked by Mohosin Sarkar
-
#EvolveImmune is hiring! Know anyone who might be interested? Visit our website to learn more about our Operations Support Specialist…
#EvolveImmune is hiring! Know anyone who might be interested? Visit our website to learn more about our Operations Support Specialist…
Liked by Mohosin Sarkar
-
We are thrilled to highlight Sonali D. presentation of new data on our EVOLVE platform describing the benefits of integrated CD2 costimulation this…
We are thrilled to highlight Sonali D. presentation of new data on our EVOLVE platform describing the benefits of integrated CD2 costimulation this…
Liked by Mohosin Sarkar
-
Today Emily is 12 years cancer free and she just finished her first year at University of Pennsylvania. Our goal is to help get these advanced…
Today Emily is 12 years cancer free and she just finished her first year at University of Pennsylvania. Our goal is to help get these advanced…
Liked by Mohosin Sarkar
-
Excited to share our latest publication and this month's cover story in Science Immunology! We've uncovered an NK cell-mediated immune checkpoint…
Excited to share our latest publication and this month's cover story in Science Immunology! We've uncovered an NK cell-mediated immune checkpoint…
Liked by Mohosin Sarkar
-
Super excited to be at PEGS Boston next week. Honored to be invited to present our latest research for podium presentation. I will be giving a short…
Super excited to be at PEGS Boston next week. Honored to be invited to present our latest research for podium presentation. I will be giving a short…
Liked by Mohosin Sarkar
-
The American Society of Gene & Cell Therapy Outstanding Achievement Award, the Society's highest honor, recognizes a member who has achieved a…
The American Society of Gene & Cell Therapy Outstanding Achievement Award, the Society's highest honor, recognizes a member who has achieved a…
Liked by Mohosin Sarkar
-
This week’s #ChemSciPicks is from Jumpei Morimoto and Shinsuke Sando et al. (The University of Tokyo, Japan), titled: ‘A high-resolution structural…
This week’s #ChemSciPicks is from Jumpei Morimoto and Shinsuke Sando et al. (The University of Tokyo, Japan), titled: ‘A high-resolution structural…
Liked by Mohosin Sarkar
-
Discover how computational sequence analysis and 3D structural modeling can speed up your therapeutic discovery process, uncovering potent antibody…
Discover how computational sequence analysis and 3D structural modeling can speed up your therapeutic discovery process, uncovering potent antibody…
Liked by Mohosin Sarkar
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Mohosin Sarkar
2 others named Mohosin Sarkar are on LinkedIn
See others named Mohosin Sarkar